The pharmacology of dibenzofuran and terphenyl derivatives of DMAE and hemicholinium-3.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001572:Benzofurans / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006426:Hemicholinium 3 / Q000494:pharmacology*; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D011950:Receptors, Cholinergic / Q000187:drug effects; D013329:Structure-Activity Relationship
D001572:Benzofurans; D001713:Biphenyl Compounds; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D000804:Angiotensin II; D006426:Hemicholinium 3; D011189:Potassium Chloride; D009538:Nicotine; D000109:Acetylcholine